The independent source for health policy research, polling, and news.
17,741 - 17,760 of 112,442 Results
The U.S. is about to blow by the 8 million mark for confirmed cases of COVID-19 with new infections accelerating quickly. Hospitalizations are also on the rise and some city hospitals report bed shortages.
Today's early morning highlights from the major news organizations.
Each week, KHN finds longer stories for you to sit back and enjoy over the weekend. Part 1 is all about COVID.
Democratic vice presidential nominee Kamala Harris suspends campaign travel and in-person events after her communications director and another staffer contract COVID-19. The campaign says neither team member had contact with Harris since their positive test.
Editorial writers weigh in on these pandemic topics and others.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
News is from Germany, Israel, Russia, Congo, Burundi, Cameroon, Hong Kong, Singapore, Italy and England.
Opinion writers weigh in on these public health topics and others.
Nick Saban's COVID infection is the latest twist to a damaged football season in the Southeastern Conference. He suspects his travels to Mississippi last weekend for a game. News is on winter sports and the NFL, as well.
The Republican-led legislation has opposed expanding nondiscriminatory protections to LGBTQ residents. News is from Utah, Michigan, Wisconsin, Vermont, and Massachusetts.
With the approval, there are now both a vaccine — Merck’s Ervebo — and a therapeutic to battle Ebola Zaire, one of the deadliest infections known to humankind. The treatment, Inmazeb, is an antibody cocktail made by Regeneron Pharmaceuticals, the same company that is developing a monoclonal antibody treatment for COVID that was given to President Donald Trump this month.
A surge in COVID cases across the United States, as well as a lack of precise information about how the virus spreads indoors, threatens holiday celebrations this year.
The insurer waived some costs and propped up providers during the pandemic. News is on a rapid growth in concentrated insurance markets and artificial intelligence, as well.
EpiVacCorona, described as a "peptide-based shot," has yet to even begin large-scale trials. Russia announced its first vaccine, Sputnik V, on Aug. 11.
Negotiations over an additional coronavirus relief package remain stalled, as both sides are still at odds over issues like employer liability and oversight of aid to states.
In his ruling, federal judge Bernard Friedman called Tennessee's 48-hour waiting period “gratuitously demeaning" as well as "highly insulting and paternalistic" to women seeking an abortion. Meanwhile, Texas' attorney general indicates he will seek an appeal of another abortion law just blocked in court.
In settlement of a lawsuit filed by Montana Gov. Steve Bullock, the U.S. Postal Service agreed to reverse recent changes that have delayed mail delivery in the lead-up to the election.
As the presidential candidates prepare for tonight's separate town hall events — to be controversially broadcast at the same time — Democratic presidential nominee Joe Biden hones his health care message to voters. Meanwhile, President Donald Trump downplays the COVID pandemic.
The rosy picture the Trump administration painted for the public in the early weeks of the coronavirus outbreak contrasts with the more dire closed-door briefings provided by economists to administration officials and Republican donors and passed along to investors, the New York Times reports. In other administration news: Dr. Deborah Birx's role in undermining WHO and efforts to halt Nevada from using Chinese-made COVID test kits.
The Centers For Medicare and Medicaid Services is also adding additional telehealth services to coverage.
© 2026 KFF